Psoriasis Trials in Rapid City, United States
Conditions / Psoriasis / Rapid City, United States
Clinical trials for Psoriasis investigate a range of treatment strategies and patient populations.
17 total trials for this combination
Showing top 10 of 17 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01163253 | A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis | TERMINATED | PHASE3 |
| NCT03047395 | A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS ) | COMPLETED | PHASE3 |
| NCT01708590 | Efficacy, Safety, and Withdrawal and Retreatment With Brodalumab in Moderate to Severe Plaque Psoriasis Subjects | TERMINATED | PHASE3 |
| NCT03611751 | An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo and a Currently Available Treatment in Participants With Moderate-to-Severe Plaque Psoriasis | COMPLETED | PHASE3 |
| NCT01831466 | Tofacitinib Ointment For Chronic Plaque Psoriasis | COMPLETED | PHASE2 |
| NCT01309737 | A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis | COMPLETED | PHASE3 |
| NCT03421197 | A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) | COMPLETED | PHASE2 |
| NCT05655299 | VTX958 Versus Placebo for the Treatment of Moderate to Severe Psoriasis | TERMINATED | PHASE2 |
| NCT05044234 | A Study to Assess Adverse Events and Disease Activity With Cedirogant (ABBV-157) in Adult Participants With Moderate to Severe Psoriasis | TERMINATED | PHASE2 |
| NCT04036435 | Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With Psoriasis | ACTIVE_NOT_RECRUITING | PHASE3 |